• Acetylcysteine: Redox Design for Complex Assays

  2026-09-15

  Acetylcysteine and N-acetyl-L-cysteine are versatile tools for dissecting glutathione biology, oxidative stress pathway modulation, and mucosal redox chemistry. This article translates lessons from an advanced metastatic TNBC nanoplatform into practical decisions for interpreting redox-sensitive assays without overstating what NAC can prove.

• alpha-ketoglutarate in Reliable Cell Assays

  2026-09-14

  A practical, evidence-based guide to using alpha-ketoglutarate in viability, proliferation, cytotoxicity, and metabolic-reprogramming workflows. It explains how SKU M1277 can support controlled dosing, interpretation of metabolic readouts, and reproducible enzyme-system studies.

• Macrophage TIPE2 Links Mitochondrial Fission to ASC Ferropto

  2026-09-13

  This Nature Communications study identifies a macrophage–adipose stem cell circuit that connects TIPE2 loss, mitochondrial fragmentation, impaired exosomal ferritin delivery, and adipose stem cell ferroptosis in visceral fat. Its findings position macrophage TIPE2 and the IP3R–Ca2+–Drp1 axis as mechanistic targets for understanding obesity-associated adipose dysfunction and metabolic disease.

• Acetylcysteine as a Redox Control in 3D PDAC Models

  2026-09-12

  Acetylcysteine can do more than reduce oxidative stress: in 3D pancreatic cancer models, it can function as a defined redox perturbation for testing tumor–stroma biology. This article translates organoid–fibroblast findings into rigorous assay-design decisions while separating established evidence from hypothesis-driven applications.

• Hepatic sEH, Nrf2, and Osteoporosis

  2026-09-12

  A recent pre-proof study identifies a liver–bone signaling axis in which hepatic soluble epoxide hydrolase (sEH) reduces circulating 14,15-EET, weakens Nrf2-ARE antioxidant signaling, and promotes osteoclastogenesis. By combining clinical samples, an ovariectomy-induced mouse model, liver-specific knockdown, pharmacological inhibition, and transcriptomics, the work links fatty acid epoxide metabolism to redox imbalance and bone loss.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-11

  Wang and colleagues developed a mesoporous organosilica nanoparticle that combines pancreatic acinar-cell targeting with trypsin-triggered release of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the system reduced intracellular calcium overload, inflammatory and necrotic signaling, pancreatic enzyme release, and mortality, although clinical translation remains unestablished.

• Exemestane: Steroidal Aromatase Inhibitor Guide

  2026-09-11

  Exemestane is a selective, irreversible steroidal aromatase inhibitor used to study estrogen biosynthesis inhibition. The A1296 product is characterized by nanomolar activity against human placental aromatase and is supplied for breast cancer research and hormone-related studies.

• Malate as a Translational Probe of Tumor Metabolism

  2026-09-10

  Malate is more than a tricarboxylic acid cycle intermediate: it is a controllable entry point for testing mitochondrial flux, redox balance, and immune-metabolic communication. This thought-leadership guide connects malate perturbation to the PDHA1 succinylation mechanism reported in cholangiocarcinoma while separating established evidence from forward-looking workflow recommendations.

• Sodium chloride: Buffer and QC Workflow

  2026-09-10

  Sodium chloride is an inorganic salt used to set ionic strength and support osmotic balance in buffer preparation, cell culture media, and related biochemical workflows. It should be dissolved in water and used promptly; it is not a suitable solvent for DMSO- or ethanol-based preparations and should not be treated as a pH buffer or a substitute for sterility-qualified reagents.

• Isoliensinine, Lipid Droplets, and MAFLD Fibrosis

  2026-09-09

  The reference study identifies a TRPV1–AMPK/ACC mechanism through which isoliensinine from Plumula Nelumbinis restores lipid droplets in hepatic stellate cells and attenuates MAFLD-associated fibrosis. Its combination of complementary animal models, LX-2 cell experiments, and molecular assays provides a useful framework for studying lipid droplet metabolism as a regulator of fibrogenesis.

• LLY-507: From Target Engagement to Cell Phenotype

  2026-09-09

  LLY-507 is a selective SMYD2 inhibitor for connecting methyltransferase target engagement with cancer cell phenotypes. This guide develops an evidence-based assay framework that separates direct SMYD2 inhibition from downstream proliferation, apoptosis, and fibrosis-related effects.

• Chronic Cabozantinib Rewires RCC Phosphosignaling

  2026-09-08

  This 2026 study uses quantitative phosphoproteomics to distinguish acute cytostatic signaling from chronic adaptation during Cabozantinib exposure in renal cell carcinoma. Its main contribution is the integration of phosphorylation-network remodeling with migration and invasion assays, showing sustained MET activation-loop suppression alongside selective adhesion- and stress-associated changes after long-term treatment.

• ECL Chemiluminescent Substrate Kit for Ferroptosis

  2026-09-07

  The ECL Chemiluminescent Substrate Detection Kit can convert ferroptosis pathway questions into sensitive, interpretable protein measurements. This guide uses TRIB3–SLC7A11–GPX4 research to explain assay design, signal interpretation, controls, and the limits of ECL-based evidence.

• α7nAChR, Pyroptosis, and HIV-1 BBB Injury

  2026-09-07

  The reference study identifies α7nAChR-driven pyroptosis in brain microvascular endothelial cells as a previously unrecognized mechanism of HIV-1 gp120-induced blood–brain barrier disruption. Its mechanistic analysis connects α7nAChR to the ROS/NF-κB/NLRP3 axis and shows that memantine and metformin can suppress this injury pathway in experimental models.

• Tolazoline Workflows for α2-Adrenergic Signaling

  2026-09-05

  Tolazoline enables controlled interrogation of α2-adrenergic signaling in airway and pancreatic islet models, with concentration ranges that help separate receptor antagonism from ATP-sensitive potassium channel effects. This workflow-focused guide covers exposure design, functional readouts, troubleshooting, and the limits of translating continuous-delivery concepts into bench assays.

8671 records 7/579 page Previous Next First page 上5页 678910 下5页 Last page